Jun 20, 2019 | Uncategorized
Adial Reaffirms on Track to Commence Phase 3 Trial in Q3 2019 Charlottesville, VA – June 6, 2019 – Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction,...
Jun 20, 2019 | Uncategorized
Patent protected FLEXITAB technology delivers flexible and precise dosing from a single extended release tablet CUMBERLAND, RI – May [31], 2019 – TEDOR Pharma Inc., a Contract Development and Manufacturing Organization with an 18-year operating history, is pleased to...
Jun 20, 2019 | Uncategorized
ProThera Biologics Awarded $2-Million Fast Track NIH Grant Company is Developing an Important Biomarker to Assess Outcomes in Neonates with Sepsis or Necrotizing Enterocolitis (NEC) in Support of Its Therapeutic  Development Programs Providence, R.I., June 19, 2019 –...
Jun 11, 2019 | Uncategorized
URI awarded $20 million to further expand biomedical research capacity in R.I. More than $80 million awarded to URI since program began in 2001 KINGSTON, R.I.– June 10, 2019 – A University of Rhode Island-based initiative that has successfully expanded biomedical...
Jun 11, 2019 | Uncategorized
By Kurt Mayer, Providence Journal Posted on providencejournal.com Jun 10, 2019 at 7:17 PM   Wondering what’s up with Rhode Island’s efforts to develop a life-sciences economy? You might find answers at a conference Wednesday morning at Brown University’s Warren...
Jun 6, 2019 | Uncategorized
https://ri-bio.org/wp-content/uploads/2019/06/RI-Bio-Live-FB.mp4 RI Bio’s Executive Director, Carol Malysz, speaks with Commerce RI’s Matt Sheaff at BIO International about how the life science industry is growing rapidly in Rhode Island. RI Bio...
